Inferra AI / Company / RXO

Rxo, Inc.

RXO · Industrials

Last earnings Oct 29, 2026

Key results

Revenuequarter

$1.4 billion

Companywide Results RXO s revenue was $1.4 billion for the third quarter, compared to $1.0 billion in the third quarter of 2024.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Gross marginquarter

16.5%

Gross margin was 16.5%, compared to 17.3% in the third quarter of 2024.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Adjusted net incomequarter

$2 million

Adjusted net income in the quarter was $2 million, compared to adjusted net income of $7 million in the third quarter of 2024.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

EPSquarter

$0.09

Transaction, integration, restructuring and other costs, and amortization of intangibles, impacted GAAP earnings per share by $0.09, net of tax.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Adjusted EPSquarter

$0.01

Adjusted diluted earnings per share was $0.01.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Brokerage gross marginquarter

13.5%

Brokerage gross margin was 13.5% in the third quarter.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

RXO s complementary services gross margin was 21.3% for the quarter.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Brokerage3 Volume: Up 1% y/y LTL: Up 43% y/y, 31% of volume TL: Down 11% y/y, 69% of volume TL volume mix: 71% contract, 29% spot Gross margin: 13.5% Productivity gains: +19%4 Complementary services Managed Trans.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

AI analysis

Q3 2025 · reported Nov 6, 2025

Based on: Earnings release + Q3 2025 deck + parent 8-K — transcript not held

Revenue · Q3 2025
$1.4B
+40.0% +$400M vs year ago computed from stated figures
EX-99 · Nov 6, 2025
EPS · Q3 2025
$0.09
EX-99 · Nov 6, 2025
Gross margin · Q3 2025
16.5%
-0.8 pts vs year ago computed from stated figures
EX-99 · Nov 6, 2025
Adjusted net income · Q3 2025
$2M
EX-99 · Nov 6, 2025

The quarter in charts

Revenue — quarterly

As stated

00.511.5$1.0BSame quarter last year$1.4BQ3 2025

EX-99 · Nov 6, 2025 Statement values as stated in the release.

GAAP gross margin

Percent of revenue, as stated

0%10%20%17.3%Same quarter last year16.5%Q3 2025

EX-99 · Nov 6, 2025 Margin values as stated in the release.

Headline figures

MetricQ3 2025Prior qtrYear ago
Revenue$1.4 billion$1.4 billion$1.0 billion
Gross margin16.5%14.4%17.3%
Adjusted net income$2 million$7 million—
EPS$0.09$0.09—
Adjusted EPS$0.01$0.09—
Brokerage gross margin13.5%14.4%—

EX-99 · Nov 6, 2025

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported

Margin

Gross margin16.5%
Brokerage gross margin13.5%

Capital allocation

The non-GAAP financial measures in this presentation include: adjusted earnings before interest, taxes, depreciation and amortization ( EBITDA margin ); adjusted EBITDA margin; bank-adjusted EBITDA; free cash flow and free cash flow as a percentage of adjusted EBITDA ( free cash flow conversion ); adjusted free cash flow and adjusted free cash flow as a percentage of adjusted EBITDA ( adjusted free cash flow conversion ); net debt, gross leverage and net leverage; and adjusted net income and adjusted diluted income per share ( adjusted diluted EPS ).

We believe that free cash flow, free cash flow conversion, adjusted free cash flow and adjusted free cash flow conversion are important measures of our ability to repay maturing debt or fund other uses of capital that we believe will enhance stockholder value, and may assist investors with assessing trends in our underlying business.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

As we navigate this market, everyone at RXO remains focused on delivering results for our customers, carriers, employees and shareholders

Based on: Earnings release + Q3 2025 deck + parent 8-K — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

The non-GAAP financial measures in this presentation include: adjusted earnings before interest, taxes, depreciation and amortization ( EBITDA margin ); adjusted EBITDA margin; bank-adjusted EBITDA; free cash flow and free cash flow as a percentage of adjusted EBITDA ( free cash flow conversion ); adjusted free cash flow and adjusted free cash flow as a percentage of adjusted EBITDA ( adjusted free cash flow conversion ); net debt, gross leverage and net leverage; and adjusted net income and adjusted diluted income per share ( adjusted diluted EPS ).

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

We believe that free cash flow, free cash flow conversion, adjusted free cash flow and adjusted free cash flow conversion are important measures of our ability to repay maturing debt or fund other uses of capital that we believe will enhance stockholder value, and may assist investors with assessing trends in our underlying business.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

We believe that net debt, gross leverage and net leverage are important measures of our overall liquidity position.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

Net debt is calculated by removing cash and cash equivalents from the principal balance of our total debt.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

Gross leverage is calculated as the principal balance of our total debt as a ratio of trailing twelve months bank-adjusted EBITDA.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

Net leverage is calculated as net debt as a ratio of trailing twelve months bank-adjusted EBITDA.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

Strategy & priorities

Market tightness is expected to persist throughout the fourth quarter, squeezing contractual brokerage gross margin New cost initiatives expected to yield more than $30 million of incremental savings CHARLOTTE, N.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

As we navigate this market, everyone at RXO remains focused on delivering results for our customers, carriers, employees and shareholders.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Wilkerson continued, RXO is well positioned because of our scale as the third-largest brokered transportation provider in North America and the strategic decisions we ve made this year.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Our best-in-class technology is enabling us to realize the benefits of our larger scale, and our new cost initiatives are expected to yield more than $30 million of savings.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

3 Q3 2025 highlights 1 Volume outperformance in a continued soft market 2 Continued Last Mile stop growth 3 Strong adjusted free cash flow conversion 4 Full-truckload market has tightened significantly, driven by capacity exits 5 New cost initiatives to enhance operational efficiency RXO is well positioned to deliver strong profitable growth across market cycles 4 Q3 2025 results Revenue by service offering excludes impact of eliminations.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

Risks & headwinds

RXO 3Q 2025 Earnings Press Release 3 These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.

SEC original ↗Rxo, Inc. — Presentation / slide deck (8-K exhibit)EX-99Nov 6, 2025

What changed vs prior quarter

Revenue — prior quarter passage and this quarter's passage are both cited.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Gross margin — prior quarter passage and this quarter's passage are both cited.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Adjusted net income — prior quarter passage and this quarter's passage are both cited.

SEC original ↗Rxo, Inc. — Earnings release (8-K exhibit)EX-99Nov 6, 2025

Documents

Earnings deck slides

6 decks with slide view

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Rxo, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Slide history — recurring slides by stated title

Slides are matched across this company’s decks by their stated title only; a title listed here appeared in more than one held deck.

Emerging growth company — Oct 29, 2026 · slide 2 · Oct 29, 2026 · slide 2 · Oct 29, 2026 · slide 2 · Oct 29, 2026 · slide 2 · Oct 29, 2026 · slide 2 · Oct 29, 2026 · slide 2

Exhibit 31.1 — Oct 29, 2026 · slide 30 · Oct 29, 2026 · slide 40 · Oct 29, 2026 · slide 33 · Oct 29, 2026 · slide 30 · Oct 29, 2026 · slide 39 · Oct 29, 2026 · slide 30

Exhibit 31.2 — Oct 29, 2026 · slide 31 · Oct 29, 2026 · slide 41 · Oct 29, 2026 · slide 34 · Oct 29, 2026 · slide 31 · Oct 29, 2026 · slide 40 · Oct 29, 2026 · slide 31

Exhibit 32.1 — Oct 29, 2026 · slide 32 · Oct 29, 2026 · slide 42 · Oct 29, 2026 · slide 35 · Oct 29, 2026 · slide 32 · Oct 29, 2026 · slide 41 · Oct 29, 2026 · slide 32

Exhibit 32.2 — Oct 29, 2026 · slide 33 · Oct 29, 2026 · slide 43 · Oct 29, 2026 · slide 36 · Oct 29, 2026 · slide 33 · Oct 29, 2026 · slide 42 · Oct 29, 2026 · slide 33

RXO, INC. — Oct 29, 2026 · slide 1 · Oct 29, 2026 · slide 1 · Oct 29, 2026 · slide 1 · Oct 29, 2026 · slide 1 · Oct 29, 2026 · slide 1 · Oct 29, 2026 · slide 1

Table of Contents — Oct 29, 2026 · slide 4 · Oct 29, 2026 · slide 4 · Oct 29, 2026 · slide 4 · Oct 29, 2026 · slide 4 · Oct 29, 2026 · slide 4 · Oct 29, 2026 · slide 4

5.2. Weights Assigned to Performance Metrics — Oct 29, 2026 · slide 32 · Oct 29, 2026 · slide 31

RXO Annual — Oct 29, 2026 · slide 27 · Oct 29, 2026 · slide 27

RXO Annual Incentive Plan — Oct 29, 2026 · slide 28 · Oct 29, 2026 · slide 28

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Filings

33 documents

Earnings releases

11 documents

Presentations

14 documents

Transcripts

0 documents

No transcripts for Rxo, Inc. are held in this edition of the library.

Mentioned by

3 companies

Other tracked companies whose held documents mention Rxo, Inc. by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.